Latest Breaking News On - Hazard ratio - Page 1 : comparemela.com

SGLT2 Inhibitors Could Reduce Risk of Lupus Nephritis and Dialysis in Systemic Lupus Erythematosus

A propensity score matched analysis suggests use of SGLT2 inhibitors could reduce risk of negative outcomes in patients with systemic lupus erythematosus and type 2 diabetes.

James cheng chungLinkedin james cheng chungChung shan medical university hospitalHazard ratioConfidence intervalNephritis among patients with systemic lupusRedefining cardiometabolic

Pfizer s LORBRENA Study: Majority ALK+ Lung Cancer Patients Live Five Years Disease-Free

Pfizer s LORBRENA Study: Majority ALK+ Lung Cancer Patients Live Five Years Disease-Free
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

South koreaUnited statesKenneth culverRoger danseyDepartment of medical oncologyEuropean unionPeter maccallum cancer centreAmerican society of clinical oncologyPfizer incClinical affairsHazard ratioConfidence intervalClinical oncologyAnnual meetingChief development officerBenjamin solomon

Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response

Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Western australiaUnited kingdomUnited statesClayton robertsonRyan sullivanAlexandra ikeguchiImmunocore immMohammed darPaul nathanRalph torbayImmunocore holdingsHead of communicationsEuropean unionExchange commissionAmerican society for clinical oncology annual meetingExchange commission on

Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and

Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and
smdailyjournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from smdailyjournal.com Daily Mail and Mail on Sunday newspapers.

United kingdomWestern australiaUnited statesPaul nathanMohammed darImmunocore immRyan sullivanRalph torbayAlexandra ikeguchiAmerican society for clinical oncology annual meetingImmunocore holdingsEuropean unionClinical developmentAmerican societyClinical oncologySenior vice president

Tempus Announces the Clinical Launch of its MRD Testing Portfolio – IT Business Net

Tempus Announces the Clinical Launch of its MRD Testing Portfolio – IT Business Net
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesHalla nimeiriPersonalis incAnnual meetingHazard ratioChief development officer